Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

Shelley Wood

August 15, 2022

News Conference News ACC 2022

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

Todd Neale

April 08, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

Presentation Fellows 2021

Lessons Learned from a Career in Interventional Discovery

Presenter: Martin B. Leon

May 08, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Industry News

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

July 23, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Conference News ACC 2019

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

L.A. McKeown

March 18, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

Presentation TCT 2018

Results and Update From the Vessix RE-INFORCE Program

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Martin B. Leon

September 24, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

L.A. McKeown

January 18, 2018

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Advertisement

What’s Going to Be Hot at TCT 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

New Faces, New Formats, New Tech: What to Expect From TCT 2022

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Lessons Learned from a Career in Interventional Discovery

TCTMD’s Top 10 Most Popular Stories for March 2021

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

COACT: Delayed Angiography Does Not Compromise Survival in Cardiac Arrest Patients Without STEMI

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Results and Update From the Vessix RE-INFORCE Program

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content